Company Overview and News

to your dashboard

Headline News

Regeneus appoints experienced pharmaceutical executive to board

Regeneus Ltd (ASX:RGS), a clinical-stage regenerative medicine company has appointed Leo Lee as an independent non-executive director with effect from December.

Regeneus finds impressive pain relief properties in Sygenus

Regeneus (ASX:RGS) has revealed study results that highlight its Sygenus technology as showing a more potent and longer lasting effect on pain than morphine.

Regeneus Ltd granted acne patent in U.S. for Sygenus

Regeneus Ltd (ASX:RGS) has been issued a notice of allowance by the United States Patent Office for a patent related to Sygenus for the treatment of acne.

Regeneus Ltd receives milestone payment to cap off quarter

Regeneus Ltd (ASX:RGS) received its US$1 million milestone payment on June 30, 2017 for meeting the primary endpoints of its Phase 1 safety trial of Progenza in patients with knee osteoarthritis.

Regeneus to receive cash payment for trial success

Regeneus (ASX:RGS) is set to receive a milestone payment of US$1 million for meeting the primary endpoints of its Phase 1 safety trial of Progenza in patients with knee osteoarthritis.

Regeneus: Access latest PPT from Proactive's CEO Sessions

Regeneus (ASX:RGS) chief executive officer, John Martin, joined Proactive's CEO Sessions in Sydney on Wednesday 14th June and Melbourne on Thursday 15th June.

XTEK brings Homeland Security Solutions to Proactive's Spotlight CEO Sessions

The company provides a wide range of specialised products in the areas of Explosive Ordinance Disposal, Unmanned Aerial Systems and imagery, weapons/ballistic protection.

AuKing Mining delivers Mexican gold-silver to Proactive's CEO Sessions

AuKing Mining (ASX:AKN) has undergone a transformation change by acquiring an interest in a high-grade gold-silver project in Mexico.

Pioneer Resources brings demand driven commodities to Proactive's CEO Sessions

Pioneer Resources (ASX:PIO) holds a portfolio of projects in Australian and Canada which are prospective for key global demand-driven commodities.

Tlou Energy's Tony Gilby brings Southern African power pathway to Proactive's CEO Sessions

Tlou Energy (ASX:TOU, AIM:TLOU) is aiming to monetise the company's gas assets through the supply of power to Botswana and Southern Africa, with the potential for the first gas-to-power by 2019.

Regeneus brings stem cell technology to Proactive's CEO Sessions

Regeneus (ASX:RGS) flagship asset is a patented off-the-shelf stem cell technology for the treatment of knee osteoarthritis and other inflammatory conditions.

Regeneus granted key Progenza patent in Japan

Regeneus (ASX:RGS) has been granted a key patent covering the composition, manufacture and use of Progenza stem cell technology in Japan.

Regeneus advances knee osteoarthritis trial

Regeneus (ASX: RGS) has successfully met its primary endpoint of safety and tolerability for its Phase 1 safety trial of the off-the-shelf stem cell treatment Progenza in patients with knee osteoarthritis (OA).

Regeneus aligns itself with Japan’s big future

Regeneus (ASX:RGS), last week, took part in a in Austrade’s business delegation to Japan, which saw John Martin, CEO, present to over 60 pharmaceutical and healthcare companies.

Regeneus CEO taking part in delegation to Japan

Regeneus (ASX:RGS) CEO John Martin  will be participating in Austrade’s business delegation to Japan on April 18 and 19 being led by Australia’s minister for trade, tourism and investments.